DK1553832T3 - Præparater og fremgangsmåder til celleseparering - Google Patents

Præparater og fremgangsmåder til celleseparering

Info

Publication number
DK1553832T3
DK1553832T3 DK03759533T DK03759533T DK1553832T3 DK 1553832 T3 DK1553832 T3 DK 1553832T3 DK 03759533 T DK03759533 T DK 03759533T DK 03759533 T DK03759533 T DK 03759533T DK 1553832 T3 DK1553832 T3 DK 1553832T3
Authority
DK
Denmark
Prior art keywords
methods
cell separation
preparations
separation preparations
reagents
Prior art date
Application number
DK03759533T
Other languages
Danish (da)
English (en)
Inventor
Daniel P Collins
Joel H Hapke
Carol A Buchert
Original Assignee
Bioe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioe Inc filed Critical Bioe Inc
Application granted granted Critical
Publication of DK1553832T3 publication Critical patent/DK1553832T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0093—Purging against cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacture And Refinement Of Metals (AREA)
DK03759533T 2002-09-27 2003-09-26 Præparater og fremgangsmåder til celleseparering DK1553832T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41469202P 2002-09-27 2002-09-27
PCT/US2003/030265 WO2004029208A2 (en) 2002-09-27 2003-09-26 Cell separation compositions and methods

Publications (1)

Publication Number Publication Date
DK1553832T3 true DK1553832T3 (da) 2007-10-01

Family

ID=32043402

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03759533T DK1553832T3 (da) 2002-09-27 2003-09-26 Præparater og fremgangsmåder til celleseparering

Country Status (13)

Country Link
US (1) US6933148B2 (de)
EP (1) EP1553832B1 (de)
JP (1) JP4344696B2 (de)
CN (1) CN100350040C (de)
AT (1) ATE366801T1 (de)
AU (1) AU2003275260B2 (de)
CA (1) CA2499826C (de)
DE (1) DE60314898T2 (de)
DK (1) DK1553832T3 (de)
IL (1) IL167624A (de)
MX (1) MXPA05003260A (de)
RU (1) RU2346039C2 (de)
WO (1) WO2004029208A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1377353A4 (de) 2001-04-10 2005-08-31 Bioergonomics Inc Zelltrennungszusammensetzungen und -verfahren
EP1592509B1 (de) * 2003-02-13 2021-09-29 Becton, Dickinson and Company Vorrichtung zum trennen von komponenten während der blutentnahme und deren gebrauch
EP1747265B1 (de) * 2004-04-23 2011-04-20 BioE LLC Mehrfachlinien-vorläuferzellen
US8263404B2 (en) * 2005-04-08 2012-09-11 Medical Discovery Partners Llc Method for enriching rare cell subpopulations from blood
US7875453B2 (en) * 2006-06-14 2011-01-25 Bioe Llc Differentiation of multi-lineage progenitor cells to hepatocytes
CA2662340C (en) 2006-09-08 2016-08-02 Medimmune, Llc Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
US7713688B2 (en) 2007-01-26 2010-05-11 Bioe, Llc Methods and compositions for depleting specific cell populations from blood tissues
CN102112491A (zh) * 2008-06-06 2011-06-29 贝勒研究院 抗-cd8抗体阻断细胞毒素效应物的引发并导致调节性cd8+t细胞的产生
CN102149473B (zh) 2008-07-21 2014-12-31 贝克顿·迪金森公司 密度相分离装置
ES2548183T3 (es) 2008-07-21 2015-10-14 Becton Dickinson And Company Dispositivo de separación de fases de densidad
AU2009274104B2 (en) 2008-07-21 2012-06-07 Becton, Dickinson And Company Density phase separation device
CN101403749B (zh) * 2008-11-17 2012-11-07 北京大学 通过葡聚糖特异性抗体辅助诊断自身免疫性疾病的试剂盒
ES2897762T3 (es) 2009-05-15 2022-03-02 Becton Dickinson Co Dispositivo de separación de fase de densidad
RU2661107C1 (ru) * 2009-09-15 2018-07-11 Зэ Юниверсити оф Токио Новый способ получения дифференцированных клеток
US20130288227A1 (en) * 2010-11-01 2013-10-31 Daniel P. Collins Methods and compositions for cell separation of blood tissues
CA2820619C (en) * 2010-11-24 2020-01-07 Litron Laboratories, Ltd. Rapid in vivo gene mutation assay based on the pig-a gene
WO2012148549A1 (en) 2011-02-25 2012-11-01 Benaroya Research Institute Detection of an immune response
CN102839152A (zh) * 2011-06-20 2012-12-26 中国科学院上海生命科学研究院 一种快速高效获得抗原特异性b细胞的方法
ES2602500T3 (es) * 2011-11-25 2017-02-21 Miltenyi Biotec Gmbh Método de separación celular
US20140295542A1 (en) * 2013-04-01 2014-10-02 Bhc Technology Holdings Llc Cell separation compositions and methods for separating and recovering therapeutic cells in blood tissue
US9694359B2 (en) 2014-11-13 2017-07-04 Becton, Dickinson And Company Mechanical separator for a biological fluid
CN108586612A (zh) * 2018-03-27 2018-09-28 深圳联合医学科技有限公司 一种适用于检测人外周血表达cd161分子亚群淋巴细胞的单克隆抗体的制备方法
RU2020122145A (ru) * 2020-07-03 2022-01-04 Петр Иванович Никитин Композиция и способ для улучшения эффективности или снижения побочных эффектов терапевтического агента, используемого для доставки нуклеиновых кислот
CN118388650B (zh) * 2024-06-28 2024-08-27 杭州赛基生物科技有限公司 一种抗CD235a单克隆抗体及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US5877299A (en) * 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
US6117985A (en) * 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
US6146628A (en) * 1995-07-11 2000-11-14 Regents Of The University Of Minnesota And Rutgers Biotherapeutic agents comprising recombinant PAP and PAP mutants
US6491917B1 (en) * 1998-07-31 2002-12-10 Stemcell Technologies Inc. Antibody composition for debulking blood and bone marrow samples from CML patients
US6153113A (en) * 1999-02-22 2000-11-28 Cobe Laboratories, Inc. Method for using ligands in particle separation
US6448075B1 (en) * 1999-05-28 2002-09-10 Stemcell Technologies Inc. Method for separating cells using immunorosettes
EP1377353A4 (de) * 2001-04-10 2005-08-31 Bioergonomics Inc Zelltrennungszusammensetzungen und -verfahren

Also Published As

Publication number Publication date
CA2499826C (en) 2015-03-24
CA2499826A1 (en) 2004-04-08
US20040062766A1 (en) 2004-04-01
CN100350040C (zh) 2007-11-21
RU2005112731A (ru) 2006-01-20
MXPA05003260A (es) 2005-09-12
WO2004029208A3 (en) 2005-04-14
EP1553832A4 (de) 2006-02-01
JP4344696B2 (ja) 2009-10-14
EP1553832A2 (de) 2005-07-20
RU2346039C2 (ru) 2009-02-10
IL167624A (en) 2009-12-24
DE60314898D1 (de) 2007-08-23
AU2003275260A1 (en) 2004-04-19
AU2003275260B2 (en) 2008-01-24
ATE366801T1 (de) 2007-08-15
CN1735346A (zh) 2006-02-15
EP1553832B1 (de) 2007-07-11
US6933148B2 (en) 2005-08-23
WO2004029208A2 (en) 2004-04-08
JP2006500932A (ja) 2006-01-12
DE60314898T2 (de) 2008-03-13

Similar Documents

Publication Publication Date Title
DK1553832T3 (da) Præparater og fremgangsmåder til celleseparering
ATE493186T1 (de) Zelltrennungszusammensetzungen und -verfahren
ATE536187T1 (de) Hla-klasse-i- und -klasse-ii-bindende peptide und ihre verwendungen
GB9709728D0 (en) Single step method
WO2005021728A3 (en) Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
WO2004063362A3 (en) Cell cycle progression proteins
NO20052363L (no) Interferon-alfa polypeptider og konjugater
ATE512666T1 (de) Hla-bindende peptide und ihre verwendungen
SG153699A1 (en) Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
DK1532261T3 (da) Fremgangsmåder og DNA-konstrukter til produktion af polypeptider med højt udbytte
SG170065A1 (en) Human embryonic stem cell methods and podxl expression
TW200801039A (en) Separation methods
WO2004111075A8 (en) Alternative reading frame polypeptides for treatment
EP2117592A4 (de) Verfahren und zusammensetzung zur entfernung spezifischer zellpopulationen aus blutgeweben
DK1730276T3 (da) Fremgangsmåde, chip, indretning og system til ekstraktion af biologiske materialer
IL180531A0 (en) Novel sequence for improving expression of nucleic acid
DK1723233T3 (da) Fremgangsmåde til berigelse og/eller adskillelse prokaryotisk DNA ved hjælp af et protein, som specifikt binder DNA indeholdende ikke-methylerede CPG-motiver
WO2005003315A3 (en) Compositions and methods for peptide-assisted transfection
WO2007127659A3 (en) Methods and compositions for separating cells
WO2002082083A1 (fr) Electrophorese
DK1321477T3 (da) Fremgangsmåde til frembringelsen af genetisk modificerede vertebrate precursor-lymfocytter og anvendelse deraf til fremstillingen af heterologe bindende proteiner
DK1576157T3 (da) Fluorescerende proteiner fra Copepode-arter og fremgangsmåder til anvendelse af samme
EP1581797A4 (de) Verfahren zur erkennung, analyse und isolationvon nascens-proteinen
NO20065651L (no) Spesifikke bindingsmedlemmer
DE69940774D1 (de) Hla-bindende peptide und ihre verwendungen